A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...

Blood-borne biomarkers for early detection of colorectal cancer (CRC) could markedly increase screening uptake. The aim of this study was to evaluate serum carcinoembryonic antigen (CEA), CYFRA21-1 ...

Molecular landscape of colorectal cancers harboring R-spondin fusions. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not include a full text component.

Results underscore clinical utility of novel circulating tumor DNA assay to detect disease recurrence Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, ...

A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence ...

Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...